|
EP0113245B1
(en)
*
|
1982-12-29 |
1989-03-15 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Cephalosporin derivatives
|
|
CA2031927A1
(en)
|
1989-12-27 |
1991-06-28 |
Imperial Oil Limited |
Method for improving the activity maintenance of a plasma initiator
|
|
WO1991009598A1
(en)
|
1990-01-05 |
1991-07-11 |
Pfizer Inc. |
Azaoxindole derivatives
|
|
US5112820A
(en)
*
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
|
GB9109246D0
(en)
|
1991-04-30 |
1991-06-19 |
Ici Plc |
Nitrogen derivatives
|
|
DE4129603A1
(de)
|
1991-09-06 |
1993-03-11 |
Thomae Gmbh Dr K |
Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
TW263504B
(enExample)
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
|
FR2692575B1
(fr)
*
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US5468757A
(en)
|
1994-01-31 |
1995-11-21 |
Eli Lilly And Company |
6-azaindole thromboxane synthase inhibitors
|
|
CA2183571A1
(en)
|
1994-02-18 |
1995-08-24 |
Karl D. Hargrave |
2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
|
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5589482A
(en)
|
1994-12-14 |
1996-12-31 |
Pfizer Inc. |
Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
|
|
JPH0920779A
(ja)
|
1995-05-01 |
1997-01-21 |
Japan Tobacco Inc |
縮合ヘテロ５員環アゼピン化合物類及びその医薬用途
|
|
GB9610811D0
(en)
|
1996-05-23 |
1996-07-31 |
Pharmacia Spa |
Combinatorial solid phase synthesis of a library of indole derivatives
|
|
US6696448B2
(en)
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
|
US6184235B1
(en)
|
1996-08-14 |
2001-02-06 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as MCP-1 antagonists
|
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
|
CA2289102A1
(en)
|
1997-05-07 |
1998-11-12 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
|
EP0931872B1
(de)
|
1998-01-23 |
2003-04-09 |
Voith Paper Patent GmbH |
Verfahren zur Entfernung von feinen Verunreinigungen aus einer Faserstoffsuspension
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
US6525072B1
(en)
|
1998-08-31 |
2003-02-25 |
Sugen, Inc. |
Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
|
|
GB9904995D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Substituted aza-oxindole derivatives
|
|
EP1161431A4
(en)
|
1999-03-10 |
2002-04-24 |
Merck & Co Inc |
6-AZAINDOL COMPOUNDS AS AN ANTAGONISTS OF THE GONADOTROPIN RELEASE HORMONES
|
|
WO2000053178A1
(en)
|
1999-03-10 |
2000-09-14 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
AU3396000A
(en)
|
1999-03-10 |
2000-09-28 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
EP1165075A4
(en)
|
1999-03-10 |
2002-04-10 |
Merck & Co Inc |
6-AZAINDOL COMPOUNDS AS GONADOLIBERINE'S ANTAGONISTS
|
|
AU3868900A
(en)
|
1999-03-10 |
2000-09-28 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
CA2367130A1
(en)
|
1999-03-10 |
2000-09-14 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
BR9916746A
(pt)
|
1999-06-03 |
2005-01-11 |
Abbott Lab |
Compostos anti-inflamatórios que inibem adesão de célula
|
|
HK1045306A1
(zh)
|
1999-06-03 |
2002-11-22 |
Abbott Laboratories |
抑制细胞黏附的抗炎化合物
|
|
JP2004502642A
(ja)
|
2000-02-11 |
2004-01-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
|
|
US20020061892A1
(en)
|
2000-02-22 |
2002-05-23 |
Tao Wang |
Antiviral azaindole derivatives
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
SK15432002A3
(sk)
|
2000-04-28 |
2004-01-08 |
Baxter Healthcare Sa |
2-acylindolové deriváty a ich použitie ako protinádorového prípravku
|
|
TWI310035B
(en)
|
2000-04-28 |
2009-05-21 |
Acadia Pharm Inc |
Muscarinic agonists
|
|
US7332494B2
(en)
|
2000-08-14 |
2008-02-19 |
Janssen Pharmaceutica, N.V. |
Method for treating allergies using substituted pyrazoles
|
|
HK1052705B
(en)
|
2000-08-14 |
2006-09-29 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted pyrazole
|
|
US7342016B2
(en)
|
2000-08-30 |
2008-03-11 |
Schering Corporation |
Farnesyl protein transferase inhibitors as antitumor agents
|
|
ATE402699T1
(de)
|
2000-09-06 |
2008-08-15 |
Ortho Mcneil Pharm Inc |
Verwendung von substituierten pyrazolen zur behandlung von allergien
|
|
CN1642973A
(zh)
|
2000-09-06 |
2005-07-20 |
奥索-麦克尼尔药品公司 |
治疗变态反应的方法
|
|
WO2002028831A1
(en)
|
2000-10-02 |
2002-04-11 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
CA2434068A1
(en)
|
2001-01-17 |
2002-07-25 |
Amura Therapeutics Limited |
Inhibitors of cruzipain and other cysteine proteases
|
|
US20030207910A1
(en)
|
2001-02-02 |
2003-11-06 |
Tao Wang |
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
|
|
PL364279A1
(en)
|
2001-02-02 |
2004-12-13 |
Bristol-Myers Squibb Company |
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
|
|
WO2002072549A1
(en)
|
2001-03-12 |
2002-09-19 |
Millennium Pharmaceuticals, Inc. |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
|
|
WO2002081443A1
(en)
|
2001-04-09 |
2002-10-17 |
Chiron Corporation |
Novel guanidino compounds
|
|
WO2002092090A1
(en)
|
2001-05-14 |
2002-11-21 |
Bristol-Myers Squibb Pharma Company |
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
US20040235867A1
(en)
|
2001-07-24 |
2004-11-25 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
DE10143079A1
(de)
|
2001-09-03 |
2003-05-15 |
Zentaris Ag |
Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
|
|
WO2003022214A2
(en)
|
2001-09-06 |
2003-03-20 |
Millennium Pharmaceuticals, Inc. |
Piperazine and homopiperazine compounds
|
|
EP1438310B1
(en)
|
2001-10-19 |
2006-12-20 |
TransTech Pharma Inc. |
Beta-carbolin derivatives as ptp-inhibitors
|
|
DE10152306A1
(de)
|
2001-10-26 |
2003-07-24 |
Asta Medica Ag |
2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
|
|
TW200301251A
(en)
|
2001-12-20 |
2003-07-01 |
Wyeth Corp |
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
|
|
US20030236277A1
(en)
|
2002-02-14 |
2003-12-25 |
Kadow John F. |
Indole, azaindole and related heterocyclic pyrrolidine derivatives
|
|
DE60309852T2
(de)
|
2002-03-27 |
2007-06-06 |
Glaxo Group Ltd., Greenford |
Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden
|
|
EP1495016A2
(en)
|
2002-04-09 |
2005-01-12 |
Astex Technology Limited |
Heterocyclic compounds and their use as modulators of p38 map kinase
|
|
US20040063744A1
(en)
|
2002-05-28 |
2004-04-01 |
Tao Wang |
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
|
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
|
US6900206B2
(en)
|
2002-06-20 |
2005-05-31 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
|
|
TW200403243A
(en)
|
2002-07-18 |
2004-03-01 |
Wyeth Corp |
1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
ATE323702T1
(de)
|
2002-08-06 |
2006-05-15 |
Astrazeneca Ab |
Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
|
|
JP2005539036A
(ja)
|
2002-08-21 |
2005-12-22 |
グラクソ グループ リミテッド |
ピリミジン化合物
|
|
GB0222493D0
(en)
|
2002-09-27 |
2002-11-06 |
Glaxo Group Ltd |
Compounds
|
|
TW200418498A
(en)
|
2002-09-30 |
2004-10-01 |
Genelabs Tech Inc |
Nucleoside derivatives for treating hepatitis C virus infection
|
|
FR2845388B1
(fr)
|
2002-10-08 |
2004-11-12 |
Sanofi Synthelabo |
Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
|
|
WO2004074286A1
(en)
|
2003-02-14 |
2004-09-02 |
Wyeth |
Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
|
DK1753764T3
(da)
|
2004-06-09 |
2009-02-16 |
Glaxo Group Ltd |
Pyrrolopyridin-derivater
|